Boston Scientific Corp

Company Snapshot
300 Boston Scientific Way
Marlborough, MA 01752-1234
United States
Sector: Healthcare
Industry: Medical Devices
Full Time Employees: 45,000
https://www.bostonscientific.com
Please select from the dropdown
Company Financials

2020
2021
2022
Gross Profit
$6,403,000,000
$8,128,000,000
$8,679,000,000
Operating Income
$684,000,000
$1,824,000,000
$2,033,000,000
Net Income
($82,000,000)
$1,041,000,000
$698,000,000
2020
Gross Profit
$6,403,000,000
Operating Income
$684,000,000
Net Income
($82,000,000)
2021
Gross Profit
$8,128,000,000
Operating Income
$1,824,000,000
Net Income
$1,041,000,000
2022
Gross Profit
$8,679,000,000
Operating Income
$2,033,000,000
Net Income
$698,000,000
The above data on Boston Scientific Corp came from annual proxy statements to the SEC. You may retrieve the full proxy statement by going to the Securities and Exchange Commission (SEC) website at www.sec.gov
Top Executives
Total Cash info
Equity info
Other info
Total Compensation
Top Executives
Total Compensation
Michael Mahoney
Chairman of the Board, President and Chief Executive Officer
$3,673,678
$12,799,085
$469,197
$16,941,960
Michael Mahoney
$16,941,960
Chairman of the Board, President and Chief Executive Officer
Daniel Brennan
Executive Vice President and Chief Financial Officer
$1,666,199
$3,338,900
$247,107
$5,252,206
Daniel Brennan
$5,252,206
Executive Vice President and Chief Financial Officer
Joseph Fitzgerald
Executive Vice President and Group President, Cardiology
$1,504,827
$3,116,230
$143,529
$4,764,586
Joseph Fitzgerald
$4,764,586
Executive Vice President and Group President, Cardiology
Arthur Butcher
Executive Vice President and Group President, MedSurg and Asia Pacific
$1,105,449
$2,703,282
$364,703
$4,173,434
Arthur Butcher
$4,173,434
Executive Vice President and Group President, MedSurg and Asia Pacific
Jeffrey Mirviss
Executive Vice President and President, Peripheral Interventions
$1,114,237
$2,337,164
$110,843
$3,562,244
Jeffrey Mirviss
$3,562,244
Executive Vice President and President, Peripheral Interventions
Boston Scientific Corp listed the above executives on its annual proxy statement to the SEC for the fiscal year of 2022. You may retrieve the full proxy statement by going to the Securities and Exchange Commission (SEC) website at www.sec.gov

The sum of all cash payments made to an individual for services during a given year. It is comprised of yearly Base Pay and Bonuses

To view more detailed proxy data including previous years contact our sales team.

Contact Us

The value of stock and option awards plus long term incentives granted.

To view more detailed proxy data including previous years contact our sales team.

Contact Us

This covers all compensation that don't fit in any of these other standard categories

To view more detailed proxy data including previous years contact our sales team.

Contact Us